MAZZOCCA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 435
EU - Europa 132
AS - Asia 91
AF - Africa 5
SA - Sud America 4
OC - Oceania 2
Totale 669
Nazione #
US - Stati Uniti d'America 432
IT - Italia 60
CN - Cina 39
FR - Francia 28
VN - Vietnam 14
DE - Germania 13
TR - Turchia 12
HK - Hong Kong 10
ES - Italia 9
PT - Portogallo 7
FI - Finlandia 6
IN - India 3
JP - Giappone 3
RU - Federazione Russa 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
CA - Canada 2
DK - Danimarca 2
EG - Egitto 2
SG - Singapore 2
ZA - Sudafrica 2
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GB - Regno Unito 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
KR - Corea 1
MX - Messico 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
Totale 669
Città #
Fairfield 30
Chicago 29
Seattle 29
Ashburn 28
Houston 23
Buffalo 14
Bari 13
Dong Ket 13
Istanbul 12
San Francisco 11
Taranto 11
Wilmington 11
Boardman 10
Cambridge 9
Los Angeles 9
Francavilla Fontana 8
Ann Arbor 7
Barcelona 7
Central 6
Las Vegas 6
Woodbridge 6
Dallas 5
Helsinki 5
Nantes 4
San Jose 4
Wuhan 4
Clearwater 3
Mottola 3
New York 3
Nuremberg 3
Rome 3
San Diego 3
Schaumburg 3
Trani 3
Al Mansurah 2
Austin 2
Beijing 2
Dulles 2
Figueira da Foz Municipality 2
Guangzhou 2
Henderson 2
Herndon 2
Manduria 2
Marrero 2
Modena 2
Nice 2
Paris 2
Porto 2
Recife 2
Shanghai 2
Shenyang 2
Tokyo 2
Vila Nova de Gaia 2
Zhengzhou 2
Ahmedabad 1
Altamura 1
Argegno 1
Athens 1
Bandaicho 1
Bisceglie 1
Bitonto 1
Brockport 1
Chongqing 1
Columbus 1
Copenhagen 1
Cuenca 1
Dalian 1
Delhi 1
Des Moines 1
Erlangen 1
Falkenstein 1
Frankfurt Am Main 1
Frankfurt am Main 1
Granada 1
Hangzhou 1
Ho Chi Minh City 1
Hyderabad 1
Ithaca 1
Lincoln 1
Lyngby 1
Madison 1
Maia 1
Metz 1
Miami 1
Montreal 1
Moscow 1
Muizenberg 1
New Haven 1
Omaha 1
Oulu 1
Pasadena 1
Pittsburgh 1
Providence 1
Provo 1
Qiryat Ata 1
Riyadh 1
Rochester 1
Secaucus 1
Shatin 1
Silverton 1
Totale 424
Nome #
Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment, file dd9e0c6a-7dab-1e9c-e053-3a05fe0a45ef 175
Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma, file dd9e0c67-6cc1-1e9c-e053-3a05fe0a45ef 93
Autotaxin is a novel molecular identifier of type I endometrial cancer, file dd9e0c67-6caf-1e9c-e053-3a05fe0a45ef 77
Synergism of adipocytokine profile and ADIPOQ/TNF-α polymorphisms in NAFLD-associated mets predict colorectal liver metastases outgrowth, file dd9e0c67-a5d3-1e9c-e053-3a05fe0a45ef 76
Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D, file dd9e0c64-a00c-1e9c-e053-3a05fe0a45ef 64
Circulating levels of PAI-1 and SERPINE1 4G/4G polymorphism are predictive of poor prognosis in HCC patients undergoing TACE, file dd9e0c69-a5f2-1e9c-e053-3a05fe0a45ef 50
ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer, file dd9e0c67-438d-1e9c-e053-3a05fe0a45ef 48
Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer, file dd9e0c67-6cb1-1e9c-e053-3a05fe0a45ef 34
A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells, file dd9e0c67-3883-1e9c-e053-3a05fe0a45ef 20
Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma, file dd9e0c64-5035-1e9c-e053-3a05fe0a45ef 8
Hepatocellular Carcinoma as a Paradigm for a Systemic Evolutionary Approach to Cancer, file dd9e0c64-c5f5-1e9c-e053-3a05fe0a45ef 5
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma, file dd9e0c6a-8f54-1e9c-e053-3a05fe0a45ef 5
Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function, file dd9e0c66-5e61-1e9c-e053-3a05fe0a45ef 4
null, file dd9e0c64-5164-1e9c-e053-3a05fe0a45ef 3
Pathobiology of Hepatocellular Carcinoma and Clinical Impact, file dd9e0c67-a267-1e9c-e053-3a05fe0a45ef 3
1H-NMR metabolomics reveals a multitarget action of Crithmum maritimum ethyl acetate extract in inhibiting hepatocellular carcinoma cell growth, file dd9e0c6a-95b9-1e9c-e053-3a05fe0a45ef 3
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts, file dd9e0c63-21ff-1e9c-e053-3a05fe0a45ef 2
Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology, file dd9e0c67-6ca8-1e9c-e053-3a05fe0a45ef 2
Sorafenib: 10 years after the first pivotal trial, file dd9e0c67-6cb3-1e9c-e053-3a05fe0a45ef 2
Moving the systemic evolutionary approach to cancer forward: Therapeutic implications, file dd9e0c67-7e64-1e9c-e053-3a05fe0a45ef 2
The perplexity of targeting genetic alterations in hepatocellular carcinoma, file dd9e0c68-afe2-1e9c-e053-3a05fe0a45ef 2
A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells: Protein expression profile in LPAR6-expressing HCC cells, file 46b34708-5e81-4728-aadb-c65c0431d87b 1
Clinical Usefulness of Cancer Antigen 15-3 in Breast Cancer Patients Before and After Surgery, file dd9e0c62-8276-1e9c-e053-3a05fe0a45ef 1
A systemic evolutionary approach to cancer: Hepatocarcinogenesis as a paradigm, file dd9e0c63-8afe-1e9c-e053-3a05fe0a45ef 1
Topology of the mitochondrial cAMP-dependent protein kinase and its substrates, file dd9e0c66-4557-1e9c-e053-3a05fe0a45ef 1
Sorafenib: The gold standard therapy in advanced hepatocellular carcinoma and beyond, file dd9e0c67-a265-1e9c-e053-3a05fe0a45ef 1
Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth, file dd9e0c6b-5400-1e9c-e053-3a05fe0a45ef 1
Totale 684
Categoria #
all - tutte 1.924
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.924


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 1 0 0 0 0 0 2 1
2020/2021128 1 0 0 0 9 15 12 9 10 35 22 15
2021/2022159 11 2 3 14 20 5 7 9 8 2 54 24
2022/2023279 5 4 58 28 13 11 21 24 72 14 20 9
2023/2024110 6 7 4 15 13 8 12 18 12 12 3 0
Totale 684